Studies and trials across Europe
Our regional presence is supported by colleagues based across a number of European countries, including Armenia, Austria, Azerbaijan, Bosnia and Herzegovina, Bulgaria, Croatia, the Czech Republic, Georgia, Hungary, Moldova, Montenegro, North Macedonia, Poland, Romania, Serbia, Slovakia, and Slovenia. Beyond these locations, we also have the experience in supporting and managing studies across a wider European footprint.
Northern Europe
Norway
United Kingdom
Sweden
Denmark
Finland
Northern Europe offers advanced healthcare systems and strong research infrastructure, ensuring high-quality clinical data. It benefits from comprehensive patient registries and high participant trust, improving compliance and retention. The region provides efficient trial processes and strong ethical and regulatory standards.
Western Europe
France
Germany
Switzerland
Spain
Protugal
Italy
Greece
Western Europe provides world-class research institutions and highly developed healthcare systems. It enables access to large, diverse patient populations, supporting complex and late-phase trials. The region ensures robust regulatory frameworks and globally recognized data quality.
Benelux
Netherlands
Belgium
Luxemburg
Benelux offers a highly integrated and innovation-driven clinical research environment. It benefits from coordinated healthcare systems, strong cross-border collaboration, and advanced digital infrastructure, enabling efficient trial execution. The region provides access to well-documented patient populations, high participant engagement, and streamlined regulatory processes, ensuring rapid start-up timelines and high-quality, reliable data.
Baltic States
Estonia
Latvia
Lithuania
The Baltic states provide efficient regulatory pathways and fast study start-up timelines. They enable quick recruitment through well-organized healthcare systems and engaged populations. The region delivers high-quality data, experienced sites, and cost-efficient operations.